{"schema_version":"secwatch.filing_event.v1","accession":"0001999371-25-005717","form_type":"8-K","ticker":"TNXP","cik":"0001430306","company_name":"Tonix Pharmaceuticals Holding Corp.","filed_at":"2025-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.275049+00:00","generated_at":"2026-05-22T03:49:28.798520+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Tonix shareholders approve reverse stock split authorization and stock plan amendments at annual meeting","bullets":["Reverse stock split authorized at ratio between 1:2 and 1:250, with 1,764,316 for, 1,203,561 against.","Stock incentive plan amended to increase shares by 1,000,000; 751,420 votes for, 724,627 against.","2025 Employee Stock Purchase Plan approved with 1,134,671 votes for, 249,372 against.","Say-on-pay proposal approved with 1,045,066 votes for; frequency set to every three years.","All 8 director nominees elected; auditor EisnerAmper LLP ratified with 2,812,075 votes for."],"urls":{"canonical":"https://secwatch.observer/filing/0001999371-25-005717","json":"https://secwatch.observer/filing/0001999371-25-005717.json","markdown":"https://secwatch.observer/filing/0001999371-25-005717.md","text":"https://secwatch.observer/filing/0001999371-25-005717.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1430306/000199937125005717/0001999371-25-005717-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1430306/000199937125005717/tnxp-8k_050825.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T03:49:28.798520+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}